Recent Insight on Regulations of FBXW7 and Its Role in Immunotherapy
SCFFBXW7 E3 ubiquitin ligase complex is a crucial enzyme of the ubiquitin proteasome system that participates in variant activities of cell process, and its component FBXW7 (F-box and WD repeat domain–containing 7) is responsible for recognizing and binding to substrates. The expression of FBXW7 is...
Main Authors: | Liangliang Xing, Leidi Xu, Yong Zhang, Yinggang Che, Min Wang, Yongxiang Shao, Dan Qiu, Honglian Yu, Feng Zhao, Jian Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-06-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.925041/full |
Similar Items
-
The Role of FBXW7 in Gynecologic Malignancies
by: Riccardo Di Fiore, et al.
Published: (2023-05-01) -
E3 Ligase FBXW7 Facilitates Mycobacterium Immune Evasion by Modulating TNF-α Expression
by: Jingrui Song, et al.
Published: (2022-05-01) -
FBXW7 attenuates tumor drug resistance and enhances the efficacy of immunotherapy
by: Shimin Chen, et al.
Published: (2023-03-01) -
METTL3-mediated m6A mRNA modification of FBXW7 suppresses lung adenocarcinoma
by: Yingtong Wu, et al.
Published: (2021-03-01) -
The Highs and Lows of FBXW7: New Insights into Substrate Affinity in Disease and Development
by: Claire C. de la Cova
Published: (2023-08-01)